Effects of Rifampicin on the Pharmacokinetics of BI 425809 Following Oral Administration in Healthy Male Subjects (an Open-label, Two-period, Fixed-sequence Trial)

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 30 Sep 2024

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

29 Oct 2021 Results assessing effects of cytochrome P450 3A4 induction and inhibition on the pharmacokinetics of BI 425809 from two studies (NCT02342717, NCT03082183) published in the European Journal of Drug Metabolism and Pharmacokinetics
21 Jun 2017 Status changed from active, no longer recruiting to completed.
22 May 2017 Status changed from recruiting to active, no longer recruiting.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com